Differential Gene Expression Analysis Services
Inquiry
As a preclinical CRO specializing in oncology, Alfa Cytology provides comprehensive differential gene expression analysis services designed to identify key transcriptomic changes driving cancer initiation, progression, and therapeutic response. Leveraging RNA-seq, qPCR, and proteomics platforms, we employ rigorous statistical models to systematically screen for differentially expressed genes, alternative splicing events, and non-coding RNAs. Our services support transcriptomic comparisons, phenotypic profiling, and molecular signature characterization, providing reliable foundations for target validation and pharmacodynamic evaluation.
Introduction to Differential Gene Expression Analysis
Differential gene expression analysis is a core technology in molecular oncology research. By employing high-throughput transcriptomic approaches, it enables systematic comparison of gene expression profiles across distinct biological states to identify genes with significant expression changes. In cancer research, this technique is widely utilized to elucidate key molecular events underlying tumor development and progression, dissect the impact of genetic mutations on the transcriptome, and assess transcriptional reprogramming effects induced by drug interventions. With continuous advancements in sequencing technologies and bioinformatics methodologies, the research paradigm of differential gene expression analysis has evolved from simple differential screening to multidimensional biological interpretation. Researchers now focus not only on the number and magnitude of differentially expressed genes but also place greater emphasis on contextualizing these differences within signaling pathways, regulatory networks, and cellular functions. As a dynamic molecular hub connecting genotype and phenotype, the transcriptome's alteration patterns often directly reflect disease status, drug response, and microenvironmental perturbations.
By comparing transcriptomic profiles across different conditions, such as tumor versus normal tissues, drug-treated versus untreated groups, and sensitive versus resistant models, differential gene expression analysis enables:
- Identification of driver genes: Pinpointing core genes whose expression changes are causally linked to disease onset and progression.
- Discovery of biomarkers: Uncovering characteristic transcripts associated with disease staging, prognosis, or therapeutic efficacy.
- Elucidation of mechanisms of action: Revealing signaling pathways and molecular networks modulated by drugs.
- Subtyping of diseases: Performing molecular classification of tumors based on transcriptomic signatures to guide precision therapeutic strategies.
Fig. 1 Analysis of differential expression of microRNAs in prostate cancer. (Khorasani M, et al.; 2019)
Our Services
At Alfa Cytology, we offer comprehensive differential gene expression analysis services tailored to meet the diverse research needs of oncology investigators. Equipped with advanced sequencing platforms, high-sensitivity detection systems, and a professional bioinformatics team, we are committed to delivering high-quality data and decision-enabling biological insights to drive breakthrough discoveries in cancer research. Our services include, but are not limited to:
Whole Transcriptome Sequencing (RNA-Seq)
Whole transcriptome sequencing provides a panoramic view of the entire transcriptome, enabling detection of both known and novel transcripts, including mRNA, non-coding RNA, and fusion genes. Utilizing high-throughput sequencing platforms, we generate high-depth coverage data to support differential expression analysis, alternative splicing detection, and novel transcript discovery. This module is well-suited for unbiased discovery-driven research.
Targeted RNA Sequencing
For focused investigations, targeted RNA sequencing delivers high-depth coverage of specific genes or transcripts of interest. This approach offers exceptional sensitivity and accuracy, making it ideal for candidate gene validation, surveillance of known biomarkers, or interrogation of specific signaling pathways, while balancing high precision with cost-effectiveness.
Real-Time Quantitative PCR (qPCR)
qPCR is the gold-standard method for targeted gene expression validation. With outstanding sensitivity, specificity, and dynamic range, qPCR enables precise quantification of a limited number of target genes. This module is widely employed for biomarker validation, pharmacodynamic monitoring, and confirmatory studies following RNA-Seq results.
Non-Coding RNA Analysis
Non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play critical regulatory roles in cancer biology. Our non-coding RNA analysis service utilizes specialized library preparation and analytical workflows to identify and quantify these regulatory molecules, providing deep insights into post-transcriptional regulation and epigenetic mechanisms.
Technology Highlights
- High sequencing depth: Deep coverage enabling comprehensive transcript detection and accurate quantification.
- Broad dynamic range: Capable of detecting both low- and high-abundance transcripts.
- Extensive sample compatibility: Supports fresh frozen tissues, FFPE tissues, cultured cells, PDOs, CDX/PDX models, and liquid biopsy samples.
- Flexible experimental design: Customizable panels and tailored bioinformatics pipelines.
- Multi-omics integration: Combined transcriptomic and proteomic data analysis for deeper biological insights.
Applications of Differential Gene Expression Analysis Services
Target Discovery and Validation
By comparing tumor versus normal tissues, treated versus untreated conditions, and resistant versus sensitive models, differential expression analysis precisely pinpoints disease-associated genes, providing preliminary evidence for novel therapeutic targets.
Pharmacodynamic Evaluation
In drug-treated cell lines, PDOs, or xenograft models, monitoring global transcriptomic responses reveals the molecular impact of candidate compounds, supporting the identification of pharmacodynamic biomarkers and assessment of target engagement.
Biomarker Discovery and Patient Stratification
Identifying expression signatures associated with drug sensitivity or resistance supports the development of companion diagnostics for patient screening in clinical trials.
Elucidation of Drug Resistance Mechanisms
Comparing transcriptomes of parental versus resistant cell lines or tumors uncovers adaptive changes driving acquired resistance, informing strategies to overcome or prevent resistance.
Workflow of Differential Gene Expression Analysis Services
Project Consultation and Study Design
Our scientific team engages in in-depth discussions with you to fully understand your research objectives, sample types, and analytical requirements.
Service Selection and Customization
Based on your specific needs, we select and tailor appropriate transcriptomic solutions—whether whole transcriptome sequencing, targeted sequencing, qPCR validation, or integrated multi-omics approaches.
Sample Processing and Quality Control
Our scientists perform RNA extraction and quality assessment under rigorous quality control protocols, ensuring RNA integrity and sample suitability for downstream analyses.
Library Preparation and Data Generation
We execute library preparation, sequencing, or qPCR experiments with stringent internal quality controls, delivering high-quality, reproducible data.
Data Analysis and Interpretation
Our bioinformatics team performs customized analyses, including differential expression, pathway enrichment, alternative splicing detection, and biomarker identification, transforming raw data into biological insights.
Integration with Downstream Applications
Your gene expression data can be seamlessly integrated into our downstream application platforms, including target validation, pharmacodynamic evaluation, mechanism of action studies, and IND-enabling research.
Alfa Cytology is your most trusted partner in oncology differential gene expression research. We offer a full-spectrum transcriptomics portfolio encompassing whole transcriptome sequencing, targeted sequencing, and qPCR validation, from sample processing and data generation to advanced mining and biological interpretation, providing end-to-end data support for your target discovery and pharmacodynamic evaluation. Please feel free to contact us to obtain a customized differential gene expression analysis solution tailored to your needs.
Reference
- Khorasani M, et al. Analysis of Differential Expression of microRNAs and Their Target Genes in Prostate Cancer: A Bioinformatics Study on Microarray Gene Expression Data. Int J Mol Cell Med. 2019;8(2):103-114.
For research use only.
Related Services
